Clinical Trials Directory

Trials / Completed

CompletedNCT04202055

Immunologic Biomarker Profile of Cerebrospinal Fluid

Status
Completed
Phase
Study type
Observational
Enrollment
165 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this study was the describe the Immunologic biomarker profile of cerebrospinal fluid in multiple sclerosis patients

Conditions

Interventions

TypeNameDescription
OTHERBiomarker analysisDetection of biomarker in cerebrospinal fluid

Timeline

Start date
2018-01-02
Primary completion
2019-08-31
Completion
2019-08-31
First posted
2019-12-17
Last updated
2019-12-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04202055. Inclusion in this directory is not an endorsement.